Two Sigma Advisers »

United Therapeutics Corporation shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2013-03-31 $964k 16k 60.86
2012-12-31 $777k 1.5k 534.76
2011-12-31 $378k 8.0k 47.25
2011-06-30 $568k 10k 55.15

More positions owned by Two Sigma Advisers

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Visa Com Cl A (V)
Doordash Cl A (DASH)
Bristol Myers Squibb (BMY)
Lockheed Martin Corporation (LMT)
Cme (CME)
Pfizer (PFE)
Fortinet (FTNT)
Nike CL B (NKE)
Merck & Co (MRK)
Eli Lilly & Co. (LLY)

View all positions for Two Sigma Advisers

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
Wellington Management Company
venBio Select Advisor
State Street Corporation
Renaissance Technologies
Geode Capital Management
FMR
LSV Asset Management
AQR Capital Management
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Pacer Advisors
Hanna Zanoni
Alliancebernstein

View all funds holding United Therapeutics Corporation